CXG-63

N/A

Report date: 2026/01/15 16:22:00

Base Information

Drug NameCXG-63
Drug Alias NameICS/LAMA/LABA(Hangzhou Chance Pharmaceuticals Co Ltd)糖皮质激素/长效β2受体激动剂/长效抗胆碱能药物（杭州畅溪制药有限公司）CXG-63CXG63
ClassificationSmall molecules
Mechanisms of ActionAcetylcholine inhibitorsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Chance Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Chance Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A